To the full analysis
AnaptysBio stock: growth
ANABAnaptysBio reported $234.6M in revenue for fiscal 2025, up 157% on the prior year, up 25.6% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
36.8%
per year from 2013 to 2025, per share 4.6%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2013 | |
|---|---|---|---|
| Revenue | 25.6% | 29.6% | 36.8% |
| Revenue per share | 25.2% | 2.1% | 4.6% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2013 | $5.48M | −$5.55M | −$5.83M |
| 2014 | $15.84M | $232K | $14.46M |
| 2015 | $17.57M | −$5.41M | −$9.91M |
| 2016 | $16.68M | −$4.26M | −$9.08M |
| 2017 | $10M | −$30.07M | −$19.73M |
| 2018 | $5M | −$61.66M | −$49.57M |
| 2019 | $8M | −$97.34M | −$70.32M |
| 2020 | $75M | −$19.93M | −$14.73M |
| 2021 | $63.18M | −$57.8M | −$47.29M |
| 2022 | $10.29M | −$128.72M | −$73.95M |
| 2023 | $17.16M | −$163.62M | −$121.61M |
| 2024 | $91.28M | −$145.23M | −$135.7M |
| 2025 | $234.6M | −$13.23M | $19.61M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 25 Sep 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.